-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VUMb0kBdsa/0UPU2FfMaOg0T4JiktwFJr8uSj9pZsBhBBI8OEvgEUEKHcrO89D6I wlj6/HWkCOffB64t1vPv9w== 0000950134-01-505750.txt : 20010822 0000950134-01-505750.hdr.sgml : 20010822 ACCESSION NUMBER: 0000950134-01-505750 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20010821 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20010821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 1719862 BUSINESS ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 8-K 1 d90190e8-k.txt FORM 8-K 1 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K - -------------------------------------------------------------------------------- CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): August 21, 2001 AMEDISYS, INC. -------------- (Exact Name of Registrant as Specified in Charter) Delaware -------- (State or Other Jurisdiction of Incorporation or Organization) 0-24260 11-3131700 ------- ---------- (Commission File Number) (I.R.S. Employer Identification No.) 11100 Mead Road, Suite 300, Baton Rouge, LA 70816 ----------------------------------------------------------- (Address of principal executive offices including zip code) (225) 292-2031 -------------- (Registrant's telephone number, including area code) 2 ITEM 5. OTHER EVENTS On August 21, 2001, Amedisys, Inc., "the Company", issued a press release attached hereto as Exhibit 99.1 to announce quarter ended June 30, 2001 operating results and that the Company would host a conference call at 4:15 EDT on that same day. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (a) Financial Statements of Business Acquired. Not applicable. (b) Pro Forma Financial Information. Not applicable. (c) Exhibit No. Page 99.1(i) Press Release dated August 21, 2001 announcing quarter ended June 30, 2001 operating results and that the Company would host a conference call at 4:15 EDT that same day..................... A-1 (i) Filed herewith. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMEDISYS, INC. By: /s/ John M. Joffrion --------------------------------------- John M. Joffrion Senior Vice President of Finance Principal Accounting and Financial Officer DATE: August 21, 2001 3 INDEX TO EXHIBITS
EXHIBIT NUMBER DESCRIPTION - ------ ----------- 99.1(i) Press Release dated August 21, 2001 announcing quarter ended June 30, 2001 operating results and that the Company would host a conference call at 4:15 EDT that same day.............................A-1
(i) Filed herewith. EX-99.1 3 d90190ex99-1.txt PRESS RELEASE DATED AUGUST 21, 2001 1 For Immediate Release Exhibit 99.1 AMEDISYS ANNOUNCES SECOND QUARTER OPERATING RESULTS COMPANY RETURNS TO PROFITABILITY IN MOST RECENT QUARTER, AS EXPECTED, AND MANAGEMENT EXPECTS EARNINGS TO IMPROVE FURTHER IN SECOND HALF OF YEAR BATON ROUGE, Louisiana (August 21, 2001) - Amedisys, Inc. (OTC BB: "AMED"), one of America's leading home health nursing companies, today reported its financial results for the second quarter and first half of 2001. The Company reported net income from continuing operations of $1.2 million, or $0.15 per diluted share, for the three months ended June 30, 2001, on revenues of approximately $27.2 million. These results compared with revenues of approximately $23.3 million and a net loss from continuing operations of ($1.4 million), or ($0.36) per share, in the second quarter of 2000. For the six months ended June 30, 2001, net income from continuing operations totaled $770,000, or $0.10 per diluted share, on revenues of approximately $49.4 million. In the corresponding period of the previous year, the Company reported a net loss from continuing operations of ($2.7 million), or ($0.78) per share, on revenues approximating $46.7 million. "We are very pleased to confirm the return to profitability in our second quarter that was anticipated in a recent news release," commented William F. Borne, Chairman and Chief Executive Officer of Amedisys, Inc. "Improved second quarter revenues and earnings, relative to the prior-year period, reflect increased patient admissions, contributions from acquired companies, changes in the Medicare payment system, and a Medicare price increase that was effective April 1, 2001. Steps that management has taken to upgrade the Company's operating and information systems in recent months have positioned Amedisys for continued growth as a leader in the home nursing industry. We are optimistic that profitability will continue to improve during the second half of the fiscal year." THE COMPANY WILL PROVIDE FURTHER INFORMATION TODAY ON THESE RESULTS DURING A TELECONFERENCE CALL THAT IS SCHEDULED FOR 4:15 P.M. EDT. TO ACCESS THIS CALL, PLEASE DIAL 800-360-9865. A REPLAY OF THE CONFERENCE CALL WILL BE AVAILABLE UNTIL AUGUST 28, 2001, BY DIALING 800-428-6051. THE ACCESS CODE IS #206761 FOR THE REPLAY. Amedisys, Inc., a leading multi-regional provider of home health nursing services, is headquartered in Baton Rouge, Louisiana. Its common stock trades on the OTC Bulletin Board under the symbol "AMED". 2 This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. Additional information on this Company can be found on the World Wide Web http://www.amedisys.com For further information, please contact: John Joffrion, Senior Vice President at (225) 292-2031 or RJ Falkner & Company, Inc., Investor Relations Counsel at (800) 377-9893 or via e-mail at info@rjfalkner.com (Financial Highlights Follow) 3 AMEDISYS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (DOLLAR AMOUNTS IN 000'S, EXCEPT PER SHARE AMOUNTS) SELECTED FINANCIAL DATA
Three Months Ended Six Months Ended June 30, June 30, 2001 2000 2001 2000 ----------- ----------- ----------- ----------- Service revenue $ 27,198 $ 23,271 $ 49,370 $ 46,688 ----------- ----------- ----------- ----------- Gross margin 15,041 12,419 27,446 24,474 Total general and administrative expenses 13,231 13,240 25,515 26,112 Operating income (loss) 1,810 (821) 1,931 (1,638) Total other expense, net (631) (551) (1,161) (1,097) Net income (loss) before discontinued operations 1,179 (1,372) 770 (2,735) ----------- ----------- ----------- ----------- Income (loss) from discontinued operations, Net of income taxes 78 (2,471) (129) (2,400) Gain on sale of discontinued operations, Net of income taxes -- 2,509 -- 2,509 Net income (loss) $ 1,257 $ (1,334) $ 641 $ (2,626) =========== =========== =========== =========== Basic weighted average common shares outstanding: 5,777 3,852 5,636 3.526 Basic income (loss) per common share: Net income (loss) before discontinued Operations $ 0.20 $ (0.36) $ 0.13 $ (0.78) Income (loss) from discontinued operations, Net of income taxes 0.01 (0.64) (0.02) (0.67) Gain on sale of discontinued operations Net of income taxes -- 0.65 -- 0.71 ----------- ----------- ----------- ----------- Net income (loss) per basic share $ 0.21 $ (0.35) $ 0.11 $ (0.74) =========== =========== =========== =========== Diluted weighted average common shares outstanding: 7,920 3,852 7,750 3.526 Diluted income (loss) per common share: Net income (loss) before discontinued Operations $ 0.15 $ (0.36) $ 0.10 $ (0.78) Income (loss) from discontinued operations, Net of income taxes 0.01 (0.64) (0.02) (0.67) Gain on sale of discontinued operations, Net of income taxes -- 0.65 -- 0.71 ----------- ----------- ----------- ----------- Net income (loss) per diluted share $ 0.16 $ (0.35) $ 0.08 $ (0.74) =========== =========== =========== ===========
-----END PRIVACY-ENHANCED MESSAGE-----